{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Lake Forest",
      "state": "IL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "89361",
      "recalling_firm": "Akorn, Inc.",
      "address_1": "1925 W Field Ct Ste 300",
      "address_2": "N/A",
      "postal_code": "60045-4862",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-0460-2022",
      "product_description": "Sufentanil Citrate Injection, USP 100 mcg/2 mL (50 mcg/mL) for intravenous and epidural use, Rx only, 2 mL Ampule, Warning - May be habit forming, Preservative Free, Manufactured by Akorn, Inc. Lake Forest, IL 60045, NDC 17478-0050-02.",
      "product_quantity": "31,510 ampules",
      "reason_for_recall": "Subpotent Drug: Out of specification for assay at the 30-month stability timepoint.",
      "recall_initiation_date": "20220105",
      "center_classification_date": "20220127",
      "termination_date": "20220917",
      "report_date": "20220119",
      "code_info": "Lot # 031489A, Expiration 03/31/2022"
    }
  ]
}